Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows

v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Feb. 28, 2026
Feb. 28, 2025
Cash flows from operating activities:    
Net income $ 47,108 $ 282,855
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 244,212 248,010
Losses on marketable securities 240,458 31,401
Compensatory element of stock options 158,549 297,392
Provision for doubtful accounts 213,341 271,207
Amortization of debt issuance costs 5,136 5,246
Amortization of operating lease right-of-use asset 97,787 91,986
Changes in assets and liabilities:    
Accounts receivable (182,853) (174,098)
Prepaid expenses 178,529 (13,892)
Inventory 51,803 (34,577)
Other current assets 24,435 18,359
Deposits and other assets, net (112,647) (65,096)
Accounts payable 430,737 735,107
Accrued expenses (1,390,667) (1,473,052)
Operating lease liability (109,654) (94,564)
Deferred revenue 755,553 827,779
Net cash from operating activities 651,827 954,063
Cash flows from investing activities:    
Purchases of property and equipment (67,065) (62,053)
Purchases of marketable securities (507,304) (599,611)
Sale of marketable securities 593,473 374,180
Net cash from (used) in investing activities 19,104 (287,484)
Cash flows used in financing activities:    
Repayments of note payable (40,290) (33,878)
Repayment of line of credit (1,900,000) (1,750,000)
Proceeds from line of credit 1,200,000 2,800,000
Dividends paid 0 (2,020,539)
Net cash (used in) provided by financing activities (740,290) (1,004,417)
Decrease in cash and cash equivalents (69,359) (337,838)
Cash and cash equivalents - beginning of period 319,031 560,960
Cash and cash equivalents - end of period 249,672 223,122
Supplemental cash flow information:    
Interest 469,572 485,413
Income taxes $ 0 $ 0